News & Updates

Never smokers with selected risk factors who undergo lung cancer screening may show similar detection rates to high-risk ever smokers or even higher rates when compared with unselected never smokers, reveals a Singapore study.

Metronomic chemotherapy has emerged as an effective treatment option with low toxicity for elderly and unfit patients. In an interview with MIMS Oncology, Dr Ashley Cheng, Specialist in Clinical Oncology in private practice in Hong Kong, discussed use of metronomic oral vinorelbine (m-OV) in frail patients with advanced non-small-cell lung cancer (NSCLC) and highlighted its advantages, including convenience and favourable tolerability.

A randomized, double-blind, placebo-controlled trial from Iran reports a significant reduction in frequency of mild hot flushes with use of melatonin in patients with prostate cancer (PC) undergoing androgen deprivation therapy (ADT).

Plasma circulating tumour DNA (ctDNA) can act as a biomarker for the early detection of metastatic progression in patients with muscle-invasive bladder cancer (MIBC) treated with bladder-sparing trimodality therapy (TMT), suggests a study.